产品名称
9-PAHSA-d9, Avanti Research™ - A Croda Brand 860409C
assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (860409C-1mg), pkg of 1 × 1 mL (860409C-500ug)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860409C
concentration
0.5 mg/mL (860409C-500ug), 1 mg/mL (860409C-1mg)
shipped in
dry ice
storage temp.
−20°C
SMILES string
CCCCCCCCCC(OC(CCCCCCCCCCCC([2H])(C([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])[2H])=O)CCCCCCCC(O)=O
InChI key
MHQWHZLXDBVXML-NPNXCVMYSA-N
General description
9-PAHSA-d9 9-[((13,13,14,14,15,15,16,16,16-d9)palmitoyl)hydroxy]-stearic acid is a deuterated palmitoyl hydroxy-stearic acid wherein the nine protons of palmitoyl are replaced by deuterium. Palmitic acid-9-hydroxy-stearic acid (9-PAHSA) is the most abundantly found fatty acid ester of hydroxy fatty acids (FAHFA).
PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes. Avanti has obtained a license from the patent holder to manufacture these products for research use.
Packaging
5 mL Clear Glass Sealed Ampule (860409C-1mg)
5 mL Clear Glass Sealed Ampule (860409C-500ug)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
signalword
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
target_organs
Liver,Kidney, Respiratory system
存储类别
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 3
flash_point_f
does not flash
flash_point_c
does not flash